Velocity Clinical Research, Banning ( Site 0017) — San Bernardino, California

Velocity Clinical Research, Banning ( Site 0017) is a clinical research site located in San Bernardino, California, United States 92408.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Velocity Clinical Research, Banning ( Site 0017) has participated in 1 clinical trials.

Therapeutic areas: Hypercholesterolemia, Familial Hypercholesterolemia.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Velocity Clinical Research, Banning ( Site 0017)?

Velocity Clinical Research, Banning ( Site 0017) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Velocity Clinical Research, Banning ( Site 0017) conducted?

Velocity Clinical Research, Banning ( Site 0017) has 1 clinical trials on record. Their work covers Hypercholesterolemia, Familial Hypercholesterolemia.

Is Velocity Clinical Research, Banning ( Site 0017) accredited by Crixeo Health?

Velocity Clinical Research, Banning ( Site 0017) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Velocity Clinical Research, Banning ( Site 0017)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.